← Open Payments lookup

SAMUEL ROSS: Open Payments

NPI 1689917486 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$752 in 31 payments from 11 companies in 2025. Trend: 2023 $809 · 2024 $647 · 2025 $752

Food & beverage: $752
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$256
Sumitomo Pharma America, Inc.4$101
Novo Nordisk Inc3$74
Novartis Pharmaceuticals Corporation3$56
PFIZER INC.2$54
Currax Pharmaceuticals LLC3$50
ABBVIE INC.2$42
Gilead Sciences, Inc.1$32
GlaxoSmithKline, LLC.1$30
Lilly USA, LLC1$30

Products named: GEMTESA, AIRSUPRA, LEQVIO, NURTEC ODT, CONTRAVE, Wegovy, BREZTRI, VRAYLAR.

Industry payments across CA — which companies pay providers there.